BALDELMO
Expert
- 42
Novo Nordisk is providing advance notice that we will be discontinuing Levemir® in the U.S.
• Mid-January: expected supply disruptions of Levemir® FlexPen®
• April 1, 2024: Levemir® FlexPen® will be discontinued
• December 31: 2024, Levemir® vial will be discontinued
This is due to a combination of factors, most notably global manufacturing constraints, significant formulary losses impacting patient access effective in January 2024, and the availability of alternative options in the U.S. market.
Our top priority is always the health and safety of the patients that use our products. We made this decision after careful consideration and are confident that patients will be able to access alternative treatments in the U.S.
In advance of this upcoming supply disruption and discontinuation, we recommend that you proactively talk to your healthcare provider about alternative treatment options to ensure continuity of care.
Should you have any additional questions, please contact your healthcare provider or reach out to the Novo Nordisk Customer Care Center at 800-727-6500.
Please see link to Prescribing Information above.
• Mid-January: expected supply disruptions of Levemir® FlexPen®
• April 1, 2024: Levemir® FlexPen® will be discontinued
• December 31: 2024, Levemir® vial will be discontinued
This is due to a combination of factors, most notably global manufacturing constraints, significant formulary losses impacting patient access effective in January 2024, and the availability of alternative options in the U.S. market.
Our top priority is always the health and safety of the patients that use our products. We made this decision after careful consideration and are confident that patients will be able to access alternative treatments in the U.S.
In advance of this upcoming supply disruption and discontinuation, we recommend that you proactively talk to your healthcare provider about alternative treatment options to ensure continuity of care.
Should you have any additional questions, please contact your healthcare provider or reach out to the Novo Nordisk Customer Care Center at 800-727-6500.
Please see link to Prescribing Information above.
